1. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1
    Haifeng Zhang et al, 2017, Cancer Chemother Pharmacol CrossRef
  2. YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy
    Katarína Gyurászová et al, 2016, Photochem. Photobiol. Sci. CrossRef
  3. MicroRNA: A novel target of curcumin in cancer therapy
    Hamed Mirzaei et al, 2018, J Cell Physiol CrossRef
  4. miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
    Shihua Chu et al, 2017 CrossRef
  5. MiR-181 family-specific behavior in different cancers: a meta-analysis view
    Cecilia Pop-Bica et al, 2018, Cancer Metastasis Rev CrossRef
  6. A web platform for the network analysis of high-throughput data in melanoma and its use to investigate mechanisms of resistance to anti-PD1 immunotherapy
    Florian S. Dreyer et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  7. Tumor exosomes: a double-edged sword in cancer therapy
    Wei Sun et al, 2018, Acta Pharmacol Sin CrossRef
  8. PTEN negative correlates with miR-181a in tumour tissues of non-obese endometrial cancer patients
    Nadezhda S. Geletina et al, 2018, Gene CrossRef
  9. MiR-21 improves invasion and migration of drug-resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1
    Chongyu Su et al, 2018, Cancer Med CrossRef
  10. Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China.
    Xia Shan et al, 2018, Cancer Med CrossRef
  11. MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer
    Jie Shen et al, 2018, Cancer Biology & Therapy CrossRef
  12. Role of Tumor-Derived Exosomes in Cancer Metastasis
    Ian Wee et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  13. Mechanisms of PTEN loss in cancer: It's all about diversity.
    Virginia Álvarez-Garcia et al, 2019, Semin Cancer Biol CrossRef
  14. miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma
    Wen Cai Zhang et al, 2019, Nat Metab CrossRef
  15. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells
    Pei Zhang et al, 2019, Gene: X CrossRef
  16. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells
    Pei Zhang et al, 2019, Gene CrossRef
  17. TGF-β induces liver fibrosis via miRNA-181a-mediated down regulation of augmenter of liver regeneration in hepatic stellate cells
    Parul Gupta et al, 2019, PLoS ONE CrossRef
  18. null
    Carmen V. Ferreira-Halder et al, 2019 CrossRef
  19. MicroRNA‐4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non‐small cell lung cancer
    Chunhua Ling et al, 2019, Cancer Med CrossRef
  20. MiR-181a-5p promotes anoikis by suppressing autophagy during detachment induction in the mammary epithelial cell line MCF10A
    Jia-li Wei et al, 2016, Protein Cell CrossRef
  21. LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway.
    Yiwei Liao et al, 2017, J Cell Biochem CrossRef
  22. Exosomes and cancer: From oncogenic roles to therapeutic applications
    Soheila Mohammadi et al, 2019, IUBMB Life CrossRef
  23. Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms
    Cornelia Braicu et al, 2019, Molecular Aspects of Medicine CrossRef
  24. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway
    Yan Pan et al, 2017, Oncotarget CrossRef
  25. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy
    Yu-Chieh Lee et al, 2017, Oncotarget CrossRef
  26. MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
    Irina Fadejeva et al, 2017, Oncotarget CrossRef
  27. Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma
    Laura L. Meijer et al, 2020, Annals of Surgery CrossRef
  28. miR‐181a/b therapy in lung cancer: reality or myth?
    Cornelia Braicu et al, 2019, Mol Oncol CrossRef
  29. Flaming the fight against cancer cells: the role of microRNA-93
    Milad Ashrafizadeh et al, 2020, Cancer Cell Int CrossRef
  30. Expression of miR‑181a and TGF‑β2 in lens epithelial cells of patients with cataractous retinal detachment and its clinical significance
    Yanyun Jiang et al, 2019, Exp Ther Med CrossRef
  31. Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis
    Marcelo Bonomi et al, 2018, Oncol Lett CrossRef
  32. Bioinformatics analysis of microRNA linked to ubiquitin proteasome system in traumatic osteonecrosis of the femoral head
    Ning Chen et al, 2020 CrossRef
  33. miR-1260b Activates Wnt Signaling by Targeting Secreted Frizzled-Related Protein 1 to Regulate Taxane Resistance in Lung Adenocarcinoma
    Jin Ren et al, 2020, Front. Oncol. CrossRef
  34. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
    Milad Ashrafizadeh et al, 2020, Cellular Signalling CrossRef
  35. Mechanisms of resistance to chemotherapy in non-small cell lung cancer
    Hye-Young Min et al, 2021, Arch. Pharm. Res. CrossRef
  36. Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance.
    Hongmei Cui et al, 2020, Curr Med Chem CrossRef
  37. Exosomes and MicroRNAs in Biomedical Science
    Hamed Mirzaei et al, 2022, Synthesis Lectures on Biomedical Engineering CrossRef
  38. null
    Hamed Mirzaei et al, 2022 CrossRef
  39. Hampered Lung Maturation in Methimazole-Induced Hypothyroidism in Fetal Chicken: Morphological and Molecular Correlates to Human Fetal Development
    Sigrid Bjørnstad et al, 2016, Neonatology CrossRef
  40. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
    Maria Konoshenko et al, 2022, IJMS CrossRef
  41. miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
    Hang Yan et al, 2022, Front. Pharmacol. CrossRef
  42. Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
    Amirhosein Maharati et al, 2023, Cell Div CrossRef
  43. Multi-omics immune regulatory mechanisms in lung adenocarcinoma metastasis and survival time
    Dan Liu et al, 2023, Computers in Biology and Medicine CrossRef
  44. Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
    Julija Simiene et al, 2023, BMC Cancer CrossRef